Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion (Containing Benzyl Alcohol), Due To The Potential Presence of Visible Particulates

Original Post

Summary

Company Announcement Date: August 22, 2022

FDA Publish Date: August 22, 2022

Product Type: Drugs

Reason for Announcement: Potential presence of visible particulate

Company Name: Hospira, Inc., a Pfizer Company

Brand Name: Hospira

Product Description: Propofol Injection Emulsion, USP

Company Announcement

FOR IMMEDIATE RELEASE -NEW YORK, NY., August 22, 2022 Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion (containing benzyl alcohol), 100mL Single Patient Use Glass Fliptop Vial; lot EA7470, to the user level due to visible particulates observed in two vials during annual examination of retention samples.

Risk Statement: Patients receiving the impacted product have a remote probability of experiencing potential adverse events, such as blockage of blood vessels, including decreased blood flow to the brain, heart attack, pulmonary embolus, and tissue necrosis. Hypersensitivity reactions and transmission of infectious disease can also occur.

To date, Pfizer has not received reports of any adverse events associated with this issue for this lot.

Propofol is an intravenous general anesthetic and sedation drug for use in the induction and maintenance of anesthesia or sedation. Propofol Injectable Emulsion is a terminally sterilized (TS) product. It is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration supplied in a Single Patient Use Glass Fliptop Vial.

The NDC, Lot Number, Expiration Date, and Configuration details for Propofol Injectable Emulsion are indicated below. The product lot was distributed nationwide to wholesalers/hospitals in the United States from July 16, 2020, through July 24, 2020.

ProductNDCLot
Number
Expiration
Date
PresentationConfiguration/
Count
Propofol
Injectable
Emulsion,
100 mL Single
Patient Use
Glass
Fliptop Vial
Vial: 
0409-4699-54 Tray: 
0409-4699-24
EA747001 JUNE 20231g/100 mL,
Single
Patient Use
Glass
Fliptop Vial
Tray of 10
Units 

Pfizer places the utmost emphasis on patient safety and product quality at every step in the manufacturing and supply chain process. Pfizer has notified direct consignees by letter to arrange for return of any recalled product. 

Wholesalers or hospitals with an existing inventory of the lot, which is being recalled, should discontinue use, stop distribution and quarantine immediately. If you have further distributed the recalled product, please notify your accounts and/or any additional locations which may have received the recalled product. Hospitals/Institutions should inform Healthcare Professionals in your organization of this recall. For additional assistance, call Sedgwick Inc. at 1-800-805-3093 between the hours of 8 a.m. to 5 p.m. ET, Monday through Friday.

Healthcare Professionals with questions regarding this recall can contact Pfizer using the below information.

Contact CenterContact InformationArea of Support
Pfizer Medical Information1-800-438-1985,
option 3 (8am to 9pm ET Monday through Friday)
www.pfizermedinfo.comExternal Link Disclaimer
For medical questions regarding the product
Pfizer Drug Safety1-800-438-1985, option 1 
(24 hours a day; 7 days a week)
To report adverse events and product complaints

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online
  • Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.


Company Contact Information

Consumers: Sedgwick Inc 1-800-805-3093

Media: Media Relations 1-212-733-7410

 [email protected]


Product Photos

  • Image Front Label: Propofol Injection Emulsion, 1g/100 mL (10mg/mL)
  • Image Side Label:  Coding – L EA7470 EXP.: 01 JUN 2023
Posted in